Understanding How Does Riluzole Block Glutamate Release? A Multifaceted Approach
•
3 min read
As the only FDA-approved medication demonstrated to modestly prolong survival in ALS patients, riluzole works by targeting the complex glutamatergic system to block glutamate release and prevent neurotoxicity. Its multifaceted mechanism provides a neuroprotective effect that helps to manage conditions linked to excessive glutamate signaling.
